Atrás
Rango del Día
$1.56
$2.52
Rango de 52 Semanas
$0.56
$2.54
Volumen
100
Promedio 50D / 200D
$2.08
/
$2.00
Cierre Anterior
$1.56
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 469.2 | 0.3 |
| P/B | 10.5 | 2.9 |
| ROE % | 2.3 | 3.7 |
| Net Margin % | 7.3 | 3.8 |
| Rev Growth 5Y % | 28.2 | 10.0 |
| D/E | 0.5 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2029 |
$0.00
$0.00 – $0.00
|
200 M | 0 |
| FY2028 |
$0.00
$0.00 – $0.00
|
190 M | 0 |
| FY2027 |
$0.07
$0.06 – $0.08
|
210 M | 1 |
Puntos Clave
Revenue grew 28.19% annually over 5 years — strong growth
Earnings declined -87.81% over the past year
ROE of 2.27% is below average
Debt/Equity of 0.49 — conservative balance sheet
Generating 30.44M in free cash flow
P/E of 469.21 — premium valuation
Crecimiento
Revenue Growth (5Y)
28.19%
Revenue (1Y)-57.43%
Earnings (1Y)-87.81%
FCF Growth (3Y)N/A
Calidad
Return on Equity
2.27%
ROIC-0.88%
Net Margin7.29%
Op. Margin-5.73%
Seguridad
Debt / Equity
0.49
Current Ratio2.82
Interest Coverage-0.62
Valoración
P/E Ratio
469.21
P/B Ratio10.47
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -57.43% | Revenue Growth (3Y) | -3.31% |
| Earnings Growth (1Y) | -87.81% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 28.19% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 38.10M | Net Income (TTM) | 2.78M |
| ROE | 2.27% | ROA | 1.29% |
| Gross Margin | 88.23% | Operating Margin | -5.73% |
| Net Margin | 7.29% | Free Cash Flow (TTM) | 30.44M |
| ROIC | -0.88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.49 | Current Ratio | 2.82 |
| Interest Coverage | -0.62 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 469.21 | P/B Ratio | 10.47 |
| P/S Ratio | 34.21 | PEG Ratio | -0.58 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.30B | Enterprise Value | 1.20B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 38.10M | 89.50M | 40.76M | 4.29M | 14.11M |
| Net Income | 2.78M | 22.80M | -137.55M | -137.32M | -296.48M |
| EPS (Diluted) | 0.00 | 0.03 | -0.19 | -0.19 | -0.39 |
| Gross Profit | 33.61M | 87.47M | 32.57M | -2.63M | 8.43M |
| Operating Income | -2.19M | 21.83M | -122.18M | -142.53M | -81.32M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 215.01M | 228.48M | 231.92M | 282.28M | 388.74M |
| Total Liabilities | 90.96M | 108.85M | 139.50M | 59.43M | 27.73M |
| Shareholders' Equity | 124.45M | 119.99M | 92.74M | 223.13M | 361.19M |
| Total Debt | 61.34M | 66.01M | 90.85M | 19.47M | 1.73M |
| Cash & Equivalents | 166.82M | 140.32M | 162.22M | 56.29M | 256.79M |
| Current Assets | 196.10M | 210.18M | 208.83M | 240.80M | 369.30M |
| Current Liabilities | 69.43M | 64.13M | 74.98M | 41.04M | 25.55M |